2022, Kabous, Laila, Hinz, Andreas, Philippi, Stefan

Effectuation and business model innovation (BMI) are research topics that are frequently discussed in the literature. While effectuation describes the effectual behaviour for founding a start-up with an emphasis on using currently available means, BMI is considered a way of creating a business model with long-term competitive advantages. Both approaches are valuable for start-ups pursuing growth in an uncertain environment. This work-in-progress paper presents insights from the reviewed extant literature. Further research will investigate effectuation and its enabling impact in designing innovative business models in the context of Swiss start-ups.

2020, Kabous, Laila, Verkuil, Arie Hans, Meyer, Rolf, Aeschbacher, Marc

Founded in 2019, Perseo Pharma is a preclinical-stage biotech company with a unique asset for the development of enzyme therapies. Perseo Pharma possesses an innovative and proprietary enzyme shielding technology. Founded as independent spin-off of INOFEA AG, the company focuses on therapeutic enzymes for the treatment of cancer and rare genetic diseases. Over the past three decades, 30 therapeutic enzymes have been approved by EMA and FDA generating yearly 40bn. Therapeutic enzymes address a wide variety of indications, ranging from rare genetic diseases (enzyme replacement therapies) to oncology (key tumor-element depletion therapies). This offers biotech companies different opportunities and application fields for further development of enzyme therapeutics. The goal of this research is to analyze the case based on the 7-key model and provide recommendations on the financing opportunities available for Perseo pharma.

2019, Kabous, Laila, Loosli, Christina, Philippi, Stefan, Verkuil, Arie Hans, Hinkelmann, Knut, Aeschbacher, Marc

Innovative Geschäftsmodelle rückten in den letzten Jahren verstärkt in den Fokus der betriebswirtschaftlichen Aufmerksamkeit und Forschung. Doch wie sieht der Umgang mit Geschäftsmodellinnovationen in der Praxis aus und welche Rolle spielt die Digitalisierung in diesem Zusammenhang? Im Rahmen der Swiss Innovation Challenge wurden Geschäftsmodellinnovationen ausgewertet und verglichen.